Position in INSM
as of Dec 31, 2025
· filed Feb 6, 2026
Position Value
$667,965
+$401,835 QoQ
Shares Held
3,838
+107.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025Global Retirement Partners, LLC holds $11,158,495 across 152 Biotechnology names. INSM ranks #5 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,345 | $1,969,849 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,499 | $1,157,033 | |
| 3 | GNLX |
GENELUX Corp
|
217,092 | $946,521 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,856 | $738,038 | |
| 5 | INSM |
INSMED Inc
This page
|
3,838 | $667,965 | |
| 6 | ARGX |
Argenx SE
|
730 | $613,893 | |
| 7 | EXEL |
Exelixis, Inc.
|
10,527 | $461,398 | |
| 8 | INCY |
Incyte Corp
|
4,406 | $435,180 |
All Filings in INSM
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $667,965 | 3,838 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $266,130 | 1,848 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $81,317 | 808 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $3,037 | 44 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $6,789 | 93 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $4,824 | 72 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $623 | 23 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $712 | 23 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $252 | 10 | Shares | Sole | 2023-10-13 | |
| 2023-03-31 | $255 | 15 | Shares | Sole | 2023-05-08 | |
| 2022-09-30 | $86 | 4 | Shares | Sole | 2022-11-03 | |
| No filing history on record for this holder in this stock. | ||||||